References
- WagenknechtLEZaccaroDEspelandMAKarterAJO’LearyDHHaffnerSMDiabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis studyArterioscler Thromb Vasc Biol2003231035104112702517
- ChamblessLEHeissGFolsomARRosamondWSzkloMSharrettARAssociation of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993Am J Epidemiol19971464834949290509
- O’LearyDHPolakJFKronmalRAManolioTABurkeGLWolfsonSKJrCarotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research GroupN Engl J Med199934014229878640
- ZanchettiATrials investigating the anti-atherosclerotic effects of antihypertensive drugsJ Hypertens1996Suppl 14S77S80
- WongMEdelsteinJWollmanJBondMGUltrasonic-pathological comparison of the human arterial wall. Verification of intima-media thicknessArterioscler Thromb1993134824868466883
- ZanchettiAAntiatherosclerotic effects of antihypertensive drugs: recent evidence and ongoing trialsClin Exp Hypertens1996184894998743037
- ElmfeldtDGeorgeMHubnerROlofssonBCandesartan cilexetil, a new generation angiotensin II antagonist, provides dose dependent antihypertensive effectJ Hum Hypertens199711S49S539331007
- PittBByingtonRPFurbergCDHunninghakeDBManciniGBMillerMEPREVENT InvestigatorsEffect of amlodipine on the progression of atherosclerosis and the occurrence of clinical eventsCirculation20001021503151011004140
- TerpstraWFMayJFSmitAJGraeffPAMeyboom-de JongBCrijnsHJEffects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial)J Hypertens2004221309131615201546
- StantonAVChapmanJNMayetJSeverPSPoulterNRHughesADEffects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid arteryClin Sci200110145546411672450
- ValensiPBaguetJPAsmarRNisse-DurgeatSMallionJMEffect of candesartan cilexetil on carotid intima-media thickness in hypertensive type 2 diabetic patients. MITEC study: design and baseline characteristicsBr J Diabetes Vasc Dis200771824
- Guidelines Committee, 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertensionJ Hypertens2003211011105312777938
- BaguetJPMallionJMMoreau-GaudryANoirclercMPeoc’hMSicheJPRelationships between cardiovascular remodeling and the pulse pressure in never treated hypertensionJ Hum Hypertens200014233010673727
- PignoliPTremoliEPoliAOrestePPaolettiRIntimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imagingCirculation19867139914063536154
- AriffBZambaniniAVamadevaSBarrattDXuYSeverPCandesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertensionStroke2006372381238416888272
- HandaNMatsumotoMMaedaHHougakuHOgawaSFukunagaRUltrasonic evaluation of early carotid atherosclerosisStroke199021156715722237950
- LudwigMKoftKRuckerWHunterAMDiagnosis of very early arteriosclerotic vascular wall changes using duplex sonographyKlin Wocheuschr198967442446
- HanefeldMChiassonJLKoehlerCHenkelESchaperFTemelkova-KurktschievTArcabose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose toleranceStroke2004351073107815073402
- LonnEMYusufSDzavikVDorisCYiQSmithSEffects or ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin ECirculation200110391992511181464
- EspositoKGiuglianoDNappoFMarfellaRRegression of carotid atherosclerosis by control of postprandrial hyperglycemia in type 2 diabetes mellitusCirculation200411021421915197140
- SidhuJKaposztaZMarkusHSKaskiJCEffect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitusArterioscl Thromb Vasc Biol20042493093415001452
- SimonAGariépyJMoyseDLevensonJDifferential effects of nifedipine and co-amilozide on the progression of early carotid wall changesCirculation20011032949295411413085
- ZanchettiABondMGHennningMNeissAManciaGDal PaluCCalcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosisCirculation20021062422242712417537
- ZanchettiABondMGHennigMNeissAManciaGDal PaluCRisk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on AtherosclerosisJ Hypertens1998169499619794735
- BoutouyriePBussyCHayozDHengstlerJDartoisNLalouxBLocal pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatmentCirculation20001012601260610840011
- MackinnonADJerrard-DunnePSitzerMBuehlerAvon KeglerSMarkusHSRates and determinants of site-specific progression of carotid artery intima-media thickness: the carotid atherosclerosis progression studyStroke2004352150215415243147
- SchiffrinELParkJBIntenganHDTouyzRMCorrection of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartanCirculation20001011653165910758046
- ChristensenKLMulvanyMJVasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature surveyJ Hypertens2001191001100611403346
- LudwigMStapffMRibeiroAFritschkaEThollUSmithRDComparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of 2 year, double blind, randomized, controlled studyClin Ther2002241175119312182261
- OlsenMHWachtellKNelandKBellaJNRokkedalJDige-PetersenHLosartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudyBlood Press20051417718316036498
- BenetosAGautierSLaflecheATopouchianJFranginGGirerdXBlockade of Angiotensin II type 1 receptors: effect on carotid and radial artery structure and function in hypertensive humansJ Vasc Res20003781510720881
- VraamarkTWaldemarGStrandgaardSPaulsonOBAngiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulationJ Hypertens1995137557617594439